Literature DB >> 36270993

Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life.

Kaushik Bhattacharya1, Samarpan Maiti1, Szabolcs Zahoran2, Lorenz Weidenauer3, Dina Hany1, Diana Wider1, Lilia Bernasconi1, Manfredo Quadroni3, Martine Collart2, Didier Picard4.   

Abstract

The cytosolic molecular chaperone Hsp90 is essential for eukaryotic life. Although reduced Hsp90 levels correlate with aging, it was unknown whether eukaryotic cells and organisms can tune the basal Hsp90 levels to alleviate physiologically accumulated stress. We have investigated whether and how mice adapt to the deletion of three out of four alleles of the two genes encoding cytosolic Hsp90, with one Hsp90β allele being the only remaining one. While the vast majority of such mouse embryos die during gestation, survivors apparently manage to increase their Hsp90β protein to at least wild-type levels. Our studies reveal an internal ribosome entry site in the 5' untranslated region of the Hsp90β mRNA allowing translational reprogramming to compensate for the genetic loss of Hsp90 alleles and in response to stress. We find that the minimum amount of total Hsp90 required to support viability of mammalian cells and organisms is 50-70% of what is normally there. Those that fail to maintain a threshold level are subject to accelerated senescence, proteostatic collapse, and ultimately death. Therefore, considering that Hsp90 levels can be reduced ≥100-fold in the unicellular budding yeast, critical threshold levels of Hsp90 have markedly increased during eukaryotic evolution.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36270993     DOI: 10.1038/s41467-022-33916-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  86 in total

1.  Environmental stress, adaptation and evolution: an overview.

Authors:  R Bijlsma; V Loeschcke
Journal:  J Evol Biol       Date:  2005-07       Impact factor: 2.411

Review 2.  Physiology and neurobiology of stress and adaptation: central role of the brain.

Authors:  Bruce S McEwen
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

Review 3.  The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease.

Authors:  S Mechiel Korte; Jaap M Koolhaas; John C Wingfield; Bruce S McEwen
Journal:  Neurosci Biobehav Rev       Date:  2004-12-10       Impact factor: 8.989

4.  Systemic stress signalling: understanding the cell non-autonomous control of proteostasis.

Authors:  Rebecca C Taylor; Kristen M Berendzen; Andrew Dillin
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

5.  Cancer is an adaptation that selects in animals against energy dissipation.

Authors:  Anthonie W J Muller
Journal:  Med Hypotheses       Date:  2017-05-30       Impact factor: 1.538

6.  Divergent Nodes of Non-autonomous UPRER Signaling through Serotonergic and Dopaminergic Neurons.

Authors:  Ryo Higuchi-Sanabria; Jenni Durieux; Naame Kelet; Stefan Homentcovschi; Mattias de Los Rios Rogers; Samira Monshietehadi; Gilberto Garcia; Sofia Dallarda; Joseph R Daniele; Vidhya Ramachandran; Arushi Sahay; Sarah U Tronnes; Larry Joe; Andrew Dillin
Journal:  Cell Rep       Date:  2020-12-08       Impact factor: 9.423

7.  Proteasome stress in skeletal muscle mounts a long-range protective response that delays retinal and brain aging.

Authors:  Mamta Rai; Zane Coleman; Michelle Curley; Anjana Nityanandam; Anna Platt; Maricela Robles-Murguia; Jianqin Jiao; David Finkelstein; Yong-Dong Wang; Beisi Xu; Yiping Fan; Fabio Demontis
Journal:  Cell Metab       Date:  2021-03-26       Impact factor: 31.373

Review 8.  Organismal proteostasis: role of cell-nonautonomous regulation and transcellular chaperone signaling.

Authors:  Patricija van Oosten-Hawle; Richard I Morimoto
Journal:  Genes Dev       Date:  2014-07-15       Impact factor: 11.361

Review 9.  Adaptive response, evidence of cross-resistance and its potential clinical use.

Authors:  Irina Milisav; Borut Poljsak; Dušan Šuput
Journal:  Int J Mol Sci       Date:  2012-08-29       Impact factor: 6.208

Review 10.  ROS in cancer therapy: the bright side of the moon.

Authors:  Bruno Perillo; Marzia Di Donato; Antonio Pezone; Erika Di Zazzo; Pia Giovannelli; Giovanni Galasso; Gabriella Castoria; Antimo Migliaccio
Journal:  Exp Mol Med       Date:  2020-02-14       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.